SMTL ID : 5dy4.2 (1 other biounit)

Crystal structure of human Sirt2 in complex with a brominated 2nd generation SirReal inhibitor and NAD+

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.77 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: C.143, C.148, C.169, C.172 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.143, A:C.148, A:C.169, A:C.172

1 x 5GN: N-{5-[(7-bromonaphthalen-1-yl)methyl]-1,3-thiazol-2-yl}-2-[(4,6-dimethylpyrimidin-2-yl)sulfanyl]acetamide(Non-covalent)

5GN.2: 17 residues within 4Å: Chain A: I.41, F.44, I.66, F.67, F.79, A.83, L.86, Y.87, P.88, F.91, I.117, D.118, F.138, I.180, V.181, F.182 Ligands: NAD.3 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:F.67, A:F.79, A:Y.87, A:F.91, A:F.138, A:F.138, A:I.180 pi-Stacking: A:F.67, A:Y.87, A:F.138, A:F.182

1 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)

NAD.3: 25 residues within 4Å: Chain A: G.32, A.33, G.34, S.36, T.37, I.41, P.42, D.43, F.44, R.45, Q.115, N.116, I.117, D.118, H.135, G.209, T.210, S.211, N.234, K.235, E.236, G.270, E.271, C.272 Ligands: 5GN.2 25 PLIP interactions: 25 interactions with chain A Hydrophobic interactions: A:F.44 Hydrogen bonds: A:A.33, A:G.34, A:T.37, A:Q.115, A:Q.115, A:I.117, A:D.118, A:D.118, A:D.118, A:H.135, A:T.210, A:S.211, A:S.211, A:N.234, A:K.235, A:C.272 Water bridges: A:T.37, A:S.38, A:R.45, A:R.45, A:R.45, A:V.214, A:D.273 Salt bridges: A:R.45

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schiedel, M. et al., Aminothiazoles as Potent and Selective Sirt2 Inhibitors: A Structure-Activity Relationship Study. J.Med.Chem. (2016)

Release Date

2016-01-13

Peptides

NAD-dependent protein deacetylase sirtuin-2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

NAD-dependent protein deacetylase sirtuin-2

Related Entries With Identical Sequence